|
Video: What is a Stock Split?
|
|
VIVUS is a pharmaceutical company with approved therapies and one product candidate in clinical development. Qsymia® (phentermine and topiramate extended release) is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. PANCREAZE®/ PANCREASE® MT (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. STENDRA® (avanafil) is approved by FDA for erectile dysfunction (ED) and by the European Commission under the trade name SPEDRA, for the treatment of ED in the European Union.VI-0106 (tacrolimus) is in clinical development and is being studied in patients with pulmonary arterial hypertension. According to our VVUS split history records, VVUS has had 2 splits. | |
|
VVUS (VVUS) has 2 splits in our VVUS split history database. The first split for VVUS took place on June 24, 1997. This was a 2 for 1
split, meaning for each share of VVUS owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. VVUS's second split took place on September 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of VVUS owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 200 share position following the split.
When a company such as VVUS splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as VVUS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the VVUS split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VVUS shares, starting with a $10,000 purchase of VVUS, presented on a split-history-adjusted basis factoring in the complete VVUS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
07/16/2020 |
|
Start price/share: |
$60.40 |
|
End price/share: |
$0.47 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.22% |
|
Average Annual Total Return: |
-53.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$77.80 |
|
Years: |
6.30 |
|
|
|
Date |
Ratio |
06/24/1997 | 2 for 1
| 09/11/2018 | 1 for 10 |
|
|